Page 81 - Sohini Das

7.5 mn need 2nd jab in July; we have 4.8 mn doses: Rajasthan minister

In a Q&A, the state's Health Minister Raghu Sharma says Rajasthan has started work to ensure no shortage of medical oxygen during the third Covid-19 wave

Covid-19 cases low but health ministry warns against 'revenge travel'

80% of new cases from 90 districts; N-E states show high case positivity rate

Seven-day average Covid-19 vaccinations at half of June 21 record

Shortage and staggered supplies seem to be playing dampener against ensuring consistent vaccination rates.

80% new Covid cases in India being reported from 90 districts, says govt

Health Ministry cautions against rising travel to tourist spots; 73 districts still reporting over 10% positivity rate; north-eastern states vulnerable

Bharat Biotech-Brazil row: Covaxin nod under controlled conditions

The agency said the suspension - which put the EUA application on ice - was due to missing data from the vaccine's clinical trials

CoWIN goes global: India makes tech open source, 142 nations show interest

This is perhaps the first time any nation is making a software platform developed by its public sector initiative open for the world

Serum Institute may double production of AstraZeneca-Oxford vaccine in 2022

Expect 200-million AstraZeneca vaccine doses next year

Covaxin 77.8% effective against symptomatic Covid-19: Bharat Biotech

The company claimed Covaxin is the first to report promising efficacy against asymptomatic infections based on qPCR testing that will help in reducing disease transmission

NPPA allows 50% price hike for ibuprofen, ranitidine, carbamazepine

These are scheduled drugs (or ones that are under price control) and low priced

Covovax denied trials on children; no nod needed for Sputnik Light

The decision comes as a setback to SII, which had sought permission to start a pediatric clinical trial of Covovax

Haven't received any payment from Brazilian health ministry: Bharat Biotech

Madison Biotech was founded by Krishna Ella in 2020 for external R&D, sales and marketing of vaccines

Cipla gets DCGI nod to import Moderna vaccine; no commercial deal yet

1st mRNA vax part of US-India pact; no commercial deal yet

We are thinking of a mega-app for Manipal Hospitals: Dilip Jose, MD&CEO

"Such a move would enable us to have virtual presence in regions where we do not yet have a physical presence, for example, the North Eastern states," said Jose

Serum Institute applies for EU nod through drugmaker AstraZeneca

SII Chief Executive Officer Adar Poonawalla said on Mon­day he had taken it up at the "highest levels".

Moderna vaccine is first mRNA jab to get emergency-use nod in India

Path cleared for importing foreign regulator-approved vaccines without bridging clinical studies; Moderna jab has 94.1% efficacy

African Union urges EU to expand vax list to include WHO-Covax vaccines

The African countries have received the Covishield jab from WHO-led Covax

Rs 50,000-cr loan guarantee for health not enough in non-metros: Industry

Finance Minister Nirmala Sithar­aman said the government would provide 75 per cent coverage for new projects and 50 per cent for those in expansion mode in the non-metros

More than 50% kids in Mumbai have Covid-19 antibodies: Sero-survey

Seropositivity is highest in the age group 10-14 years, at 53.43 per cent

Bajaj Healthcare seeks compulsory licence for Covid-19 drug Baricitinib

Eli Lilly has granted voluntary license to 6 Indian drugmakers for Baricitinib

DRL launches DRDO drug 2-DG to treat moderate to severe Covid patients

2-DG was developed by the Institute of Nuclear Medicine & Allied Sciences (INMAS), a laboratory of the Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy's